The search for a viable HIV vaccine resonates strongly among those afflicted. In light of Merck's recent, high-profile HIV vaccine failure, and media articles calling for the abandonment of HIV vaccine research, an oft-overlooked approach may now take center stage, according to HIV expert Dr. Sylvain Fleury.
Major companies are creating a wide variety of programs to help employees deal with the global HIV/AIDS epidemic, according to a report released today by The Conference Board, the global business research and membership organization.
The Feinstein Institute for Medical Research announced today that it has signed a collaborative agreement with the renowned Karolinska Institutet in Sweden.
This study of patients' genes and clinical outcomes may signal the need for a change of thought in approaching HIV management.
An increase in the CD163+/CD16+ monocyte subset, which correlates with a patient's viral load, could serve as a biomarker for the progression of HIV disease.
Food insecurity linked with HIV/AIDS in Africa Queen's-led project to develop training, advocacy programs Determining how the HIV/AIDS epidemic increases food insecurity in African cities "“ and what can be done to reduce the chances of this happening "“is the focus of a new, international Queen's-led project.
Researchers at the University of Alberta have discovered a gene that is able to block HIV, and thought to in turn prevent the onset of AIDS.
Researchers at The Scripps Research Institute have developed a new two-punch strategy against HIV and they have already successfully tested aspects of it in the laboratory.
Healthy middle-aged men who watch extensive online presentations about prostate cancer are more likely to understand the disease than those who simply visit health Web sites, a new study finds. The men are also slightly less inclined to undergo a routine but somewhat controversial prostate test, according to the study in the latest Archives of Internal Medicine.
About one in four women who have tested positive for the human immunodeficiency virus (HIV) expect pregnancy and motherhood to be a part of their future, recent research suggests.
An experimental anti-HIV gel is safe for women to use on a daily basis, according to research presented at an international microbicides meeting in New Delhi. The Phase II trial evaluated if tenofovir was safe to use every day for six months, or safe to use prior to each act of sex. Both approaches were found safe, paving the way for a larger study to see if the gel prevents HIV infection, the study authors said.
In an effort to strengthen and broaden its global health research and project implementation capabilities, RTI International has hired an internationally recognized team of researchers who together comprise the Women's Global Health Imperative formerly at the University of California at San Francisco.
An antiretroviral drug already in widespread use in the developing world to prevent the transmission of HIV from infected mothers to their newborns during childbirth has also been found to substantially cut the risk of subsequent HIV transmission during breast-feeding.
Patients with insomnia who are diagnosed with accompanying mental health ailments often are not prescribed medication that will help them sleep "“ which could then make related anxiety or depression worse, new research suggests.
Worldwide scholars and poets, authors and reviewers of African literature will convene at Western Illinois University in Macomb April 22 -27 for the 34th Annual African Literature Association Conference, "African and African Diaspora Women Writers, Global Challenges and Cultural Identity."
A new vaccine design strategy developed by scientists at The Wistar Institute could help to develop vaccines against diseases like AIDS and cervical cancer. The secret is using a herpes simplex protein called glycoprotein D to block a receptor molecule on antigen-presenting cells.
A pharmacy researcher is developing compounds that could play a major role in the fight against certain cancers, discovering novel compounds to fight the virus that causes AIDS, and finalizing development of a cream that could be used by women during intercourse to prevent HIV transmission.
UCLA researchers have found that a key protein in the body's dendritic cells can stop the virus that causes AIDS from "budding" "” part of the virus' life cycle that is crucial to its ability to replicate and infect other cells.
Josh Bristow, 51, is one of a very few patients in the nation with AIDS and late-stage heart failure to have a left ventricular assist device (LVAD) implanted as "destination therapy." He needed a heart transplant, but the immune-compromising nature of AIDS virtually excluded him as a candidate for transplantation because of the increased risk of infection and the inability to undergo immunosuppression to prevent organ rejection.
Newly homeless youth are likelier to engage in risky sexual behavior if they stay in nonfamily settings "” such as friends' homes, abandoned buildings or the streets "”because they lack supervision and social support.
A research team at Weill Cornell Medical College in New York City has identified two genes that may be crucial to the production of an immune system cytokine called interleukin-10 (IL-10).
Dr. Opendra "Bill" Narayan, PhD, DVM, an internationally-known AIDS researcher died on Dec. 24, 2007. Narayan's work included leading-edge research in producing a treatment
From stem cell research to needle exchanges to medical marijuana and HIV/AIDS prevention, politics is getting in the way of science, according to a new book by a leading authority on health-care policy and women's health issues at Weill Cornell Medical College.
The number of infants under age 2 with HIV who were hospitalized fell by 64 percent between 1998 and 2005. During the same period, hospitalizations for children and adolescents with HIV age 2 to 17 and for adults with HIV age 18 to 44 dropped by 41 percent and 31 percent, respectively.
Lausanne, Switzerland, 3 December 2007-- The Swiss Institute for Vaccine Research will be launched on December 5, 2007, in Lausanne, Switzerland. The new Institute will encompass the principal aspects of vaccine research to fight the three main infectious diseases : HIV/AIDS, tuberculosis and malaria. The Institute will also benefit from ongoing vaccine research in cancer and influenza.
Expert Available for Interviews for World AIDS Day Coverage: On World AIDS Day, people all over the world join together to educate one another about the disease, remember those who lost their lives fighting the disease, raise funds, and take action to stop the spread of HIV. The theme for the 2007 World AIDS Day is "Stop AIDS: Keep the Promise- Leadership." The focus is on getting everyone, not just the government, to take initiative and provide leadership on fighting HIV/AIDS.
Two studies found that people infected with HIV in Thailand die from the disease significantly sooner than those with HIV living in other parts of the world. The shorter survival time measured in the studies suggests that HIV subtype E, which is the most common HIV subtype in Thailand, may be more virulent than other subtypes of the virus.
This tip sheet discusses some of the AIDS- and HIV-related research conducted by Indiana University Bloomington sexual health experts, who discuss how the sexual behavior of young, rural singles is no less risky than their non-rural peers, bisexual men and AIDS/HIV prevention, and motivation for correct condom use. Dec. 1 is World AIDS Day.
AMPATH, a program that grew out of the partnership between Indiana University School of Medicine and the Moi (Kenya) University Teaching and Referral Hospital, has received a 5-year, $60-million grant to prevent and treat HIV/AIDS in Kenya. In addition, the IU School of Medicine will augment this with $6 million over the 5 years of the grant.
Leading efforts to create an HIV vaccine have hinged on the use of viruses as carriers for selected elements of the HIV virus. Recently, however, evidence has emerged that some of these so-called viral vector systems may undermine the immune system and should not be used for vaccine development. Now, a new study from scientists at The Wistar Institute provides strong support for the idea that some viral-vector vaccines may cause more harm than good.
AIDS continues to be a staggering global public health problem. However, little is known about the long-term costs associated with providing drugs to AIDS patients in developing countries. To study those long-term cost trends, researchers from the Harvard School of Public Health have performed the first detailed analysis of AIDS drug cost trends in Brazil.
People who do not have HIV but seek antiretroviral medications following high-risk sexual encounters are very likely to complete the full monthlong drug regimen. Moreover, there is a strong demand for publicly available post-exposure prophylaxis among high-risk populations in Los Angeles County.
Most people in Africa and Asia are born and die without leaving a trace in any official records, giving policymakers and researchers little information on which to base public health decisions, a University of North Carolina at Chapel Hill researcher and colleagues say in a paper published today (Oct. 29, 2007) in the British medical journal The Lancet.
Providing HIV combination antiretroviral drug therapy is key to saving the lives of African children infected with the disease. According to a study from the University of Alabama at Birmingham, letting nurses and other trained health care workers deliver that therapy and monitor patients is just as important to saving lives. The results are published in JAMA.
Smoked cannabis eased pain induced in healthy volunteers, according to a study by researchers at the University of California, San Diego (UCSD) Center for Medical Cannabis Research (CMCR.) However, the researchers found that less may be more.
Through an international collaboration, more than 200 medical and scientific journals are publishing theme issues this week on the relationship between poverty and human development. The initiative, coordinated by the Council of Science Editors, includes presentations on seven of the journal articles which will be webcast live from the National Institutes of Health on Monday, October 22, 2007.
A review of existing research suggests that people in two African countries prefer taking HIV tests at home, with the assistance of counselors, instead of at a clinic. Still, the review authors say they are not ready to call for developing countries to adopt more home-based HIV testing.
Researchers at Ohio State will spend the next two years testing their theories about just how an AIDS-like virus in cats is able to resist the powerful medicines that are thrown against it. It's one of the latest efforts at understanding one of the leading problem areas in medicine today -- antimicrobial drug resistance.
A new commentary in the Oct. 10 edition of the Journal of the American Medical Association explores whether psychological stress leads to disease and concludes that the link is likely.
A combination of drugs widely used to treat infections caused by HIV appears to stop brain damage caused by the virus as well, according to a study published in the October 9, 2007, issue of Neurology, the medical journal of the American Academy of Neurology.
Researchers have shed new light on how Kaposi's Sarcoma-associated Herpes Virus subverts normal cell machinery to cause cancer. A KSHV protein called latency-associated nuclear antigen (LANA) helps the virus hide out from the immune system in infected cells. When LANA takes the place of other proteins that control cell growth, it can cause uncontrolled cell replication.
1) Safe Candy-Consumption Tips When Trick-or-Treating; 2) State of the Health Care Industry; 3) Innovative Alternative to Relieve Chronic Knee Pain; 4) Holiday Heart Health; 5) Earwax and Hearing Aids Don't Mix
A team of tuberculosis (TB) experts at Johns Hopkins and in Brazil have evidence that substituting the antibiotic moxifloxacin in the regimen of drugs used to treat the highly contagious form of lung disease could dramatically shorten the time needed to cure the illness from six months to four.
Researchers found that when HIV patients lead chaotic lives "” meaning they are disorganized or experience too many unexpected events "” that chaos can act as a barrier to regular medical care. The researchers also developed a new scale to gauge the level of chaos in an adult's life.
The Eli and Edythe Broad Foundation is donating $20 million to fund adult and embryonic stem cell research at UCLA, enhancing a program that brings together biologists, chemists, engineers, geneticists and other scientists to develop new and more effective treatments for cancer, HIV/AIDS, Parkinson's, metabolic disorders and other medical conditions.
University of Utah biochemist Wesley I. Sundquist, Ph.D., has been awarded a five-year, $19.2 million National Institutes of Health (NIH) grant to establish an HIV research center to study the structural biology of the AIDS-causing virus.
A promising new HIV vaccine created at The Wistar Institute has received funding for clinical development aimed at moving the vaccine into human clinical trials as soon as possible. With $13.3 million in funding over five years starting September 1, the planned trials will be conducted under the auspices of the Integrated Preclinical/Clinical AIDS Vaccine Development Program of the National Institute of Allergy and Infectious Diseases.
The new study finds that up to one-fourth of patients surveyed in the Los Angeles area reported feeling stigmatized by their health care providers. This perception was also linked to low access to care among these patients, a large proportion of whom are low-income and minorities.
1) Alcohol and drug use more prevalent among Mexican migrants and their family members than other Mexicans; 2) Higher-educated individuals less likely to be persistent cocaine users; 3) Increasing cigarette prices don't discourage low-income smokers; 4) Lack of universal access to new AIDS drugs has exacerbated health disparities; 5) Damp, moldy houses may contribute to depression.
In a report that is among the first to describe the prevalence of HIV and Hepatitis B and C viruses in Afghanistan, a researcher from the UCSD School of Medicine voiced concerns that increasing injection drug use and accompanying high-risk behavior could lead to an HIV epidemic in Afghanistan.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right